BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36464090)

  • 1. Serum Annexin A2 concentrations are increased in patients with diabetic cardiomyopathy and are linked to cardiac dysfunctions.
    He Q; Zhu J; Yang G; Liu X; Li L; Wang Y; Xiong X; Zheng Y; Zheng H; Qu H
    Diabetes Res Clin Pract; 2023 Jan; 195():110196. PubMed ID: 36464090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential clinical value of fibrinogen-like protein 1 as a serum biomarker for the identification of diabetic cardiomyopathy.
    Liu Y; Wang M; Su JB; Fu X; Zheng GL; Guo S; Zhang LJ; Lu QB
    Sci Rep; 2024 May; 14(1):10311. PubMed ID: 38705920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary microvascular function is independently associated with left ventricular filling pressure in patients with type 2 diabetes mellitus.
    Kawata T; Daimon M; Miyazaki S; Ichikawa R; Maruyama M; Chiang SJ; Ito C; Sato F; Watada H; Daida H
    Cardiovasc Diabetol; 2015 Aug; 14():98. PubMed ID: 26242308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redefining Diabetic Cardiomyopathy: Perturbations in Substrate Metabolism at the Heart of Its Pathology.
    Heather LC; Gopal K; Srnic N; Ussher JR
    Diabetes; 2024 May; 73(5):659-670. PubMed ID: 38387045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymptomatic Diabetic Cardiomyopathy: an Underrecognized Entity in Type 2 Diabetes.
    Stanton AM; Vaduganathan M; Chang LS; Turchin A; Januzzi JL; Aroda VR
    Curr Diab Rep; 2021 Sep; 21(10):41. PubMed ID: 34580767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of diabetic cardiomyopathy in patients with type 2 diabetes in a large academic medical center.
    Swiatkiewicz I; Patel NT; Villarreal-Gonzalez M; Taub PR
    BMC Med; 2024 May; 22(1):195. PubMed ID: 38745169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a definite diabetic cardiomyopathy in type 2 diabetes by comprehensive echocardiographic evaluation: A cross-sectional comparison with non-diabetic weight-matched controls.
    Ofstad AP; Urheim S; Dalen H; Orvik E; Birkeland KI; Gullestad L; W Fagerland M; Johansen OE; Aakhus S
    J Diabetes; 2015 Nov; 7(6):779-90. PubMed ID: 25350248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological and proteomic profile of diabetic versus non-diabetic dilated cardiomyopathy.
    Frustaci A; Ciccosanti F; Chimenti C; Nardacci R; Corazzari M; Verardo R; Ippolito G; Petrosillo N; Fimia GM; Piacentini M
    Int J Cardiol; 2016 Jan; 203():282-9. PubMed ID: 26519687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management.
    Pappachan JM; Varughese GI; Sriraman R; Arunagirinathan G
    World J Diabetes; 2013 Oct; 4(5):177-89. PubMed ID: 24147202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The additive effects of type 2 diabetes mellitus on left ventricular deformation and myocardial perfusion in essential hypertension: a 3.0 T cardiac magnetic resonance study.
    Li XM; Jiang L; Guo YK; Ren Y; Han PL; Peng LQ; Shi R; Yan WF; Yang ZG
    Cardiovasc Diabetol; 2020 Sep; 19(1):161. PubMed ID: 32998742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and Prognostic Implications of Diabetes With Cardiomyopathy in Community-Dwelling Adults.
    Segar MW; Khan MS; Patel KV; Butler J; Tang WHW; Vaduganathan M; Lam CSP; Verma S; McGuire DK; Pandey A
    J Am Coll Cardiol; 2021 Oct; 78(16):1587-1598. PubMed ID: 34649696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between flow-mediated dilatation and left ventricular function in type 2 diabetic patients with microalbuminuria.
    Baykan M; Erdogan T; Erem C; Hacihasanoglu A; Gedikli O; Küçükosmanoglu M; Celik S; Orem C
    Endocrine; 2006 Oct; 30(2):197-202. PubMed ID: 17322579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo.
    Cao N; Wong YG; Rosli S; Kiriazis H; Huynh K; Qin C; Du XJ; Kemp-Harper BK; Ritchie RH
    Circ Heart Fail; 2015 May; 8(3):572-81. PubMed ID: 25737497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrine suppresses cardiac fibrosis by inhibiting the TGF‑β/Smad pathway in experimental diabetic cardiomyopathy.
    Zhang Y; Cui L; Guan G; Wang J; Qiu C; Yang T; Guo Y; Liu Z
    Mol Med Rep; 2018 Jan; 17(1):1775-1781. PubMed ID: 29138820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of cardiac autonomic neuropathy with subclinical myocardial dysfunction in type 2 diabetes.
    Sacre JW; Franjic B; Jellis CL; Jenkins C; Coombes JS; Marwick TH
    JACC Cardiovasc Imaging; 2010 Dec; 3(12):1207-15. PubMed ID: 21163448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Diabetic Cardiomyopathy by Cardiovascular Magnetic Resonance T1 Mapping: Correlation with Left-Ventricular Diastolic Dysfunction and Diabetic Duration.
    Shang Y; Zhang X; Leng W; Chen L; Lei X; Zhang T; Greiser A; Liang Z; Wang J
    J Diabetes Res; 2017; 2017():9584278. PubMed ID: 28791311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of glycemic variability with left ventricular diastolic function in type 2 diabetes mellitus.
    Yokota S; Tanaka H; Mochizuki Y; Soga F; Yamashita K; Tanaka Y; Shono A; Suzuki M; Sumimoto K; Mukai J; Suto M; Takada H; Matsumoto K; Hirota Y; Ogawa W; Hirata KI
    Cardiovasc Diabetol; 2019 Dec; 18(1):166. PubMed ID: 31805945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of empagliflozin in different phases of diabetes mellitus-related cardiomyopathy: a prospective observational study.
    Oka S; Kai T; Hoshino K; Watanabe K; Nakamura J; Abe M; Watanabe A
    BMC Cardiovasc Disord; 2021 Apr; 21(1):217. PubMed ID: 33926386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular deformation associated with cardiomyocyte Ca(2+) transients delay in early stage of low-dose of STZ and high-fat diet induced type 2 diabetic rats.
    Liu XY; Liu FC; Deng CY; Zhang MZ; Yang M; Xiao DZ; Lin QX; Cai ST; Kuang SJ; Chen J; Chen SX; Zhu JN; Yang H; Rao F; Fu YH; Yu XY
    BMC Cardiovasc Disord; 2016 Feb; 16():41. PubMed ID: 26879576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of myocardial scars on left ventricular deformation in type 2 diabetes mellitus after myocardial infarction by contrast-enhanced cardiac magnetic resonance.
    Gao Y; Xu HY; Guo YK; Wen XL; Shi R; Li Y; Yang ZG
    Cardiovasc Diabetol; 2021 Oct; 20(1):215. PubMed ID: 34696783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.